The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 14, 2025
Filed:
Mar. 23, 2023
Applicant:
Chemical & Biopharmaceutical Laboratories of Patras S.a., Patras, GR;
Inventors:
Kleomenis Barlos, Patras, GR;
Dimitrios Gatos, Patras, GR;
Kostas K. Barlos, Patras, GR;
Zoi Vasileiou, Patras, GR;
Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 1/04 (2006.01); A61K 47/54 (2017.01); C07C 269/04 (2006.01); C07C 269/06 (2006.01); C07C 271/02 (2006.01); C07C 323/60 (2006.01); C07K 1/107 (2006.01); C07K 14/00 (2006.01); C07K 14/47 (2006.01); C07K 14/505 (2006.01); C07K 14/575 (2006.01); C07K 14/605 (2006.01); C07K 14/62 (2006.01); C07K 14/635 (2006.01); C07K 14/695 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 1/1075 (2013.01); A61K 47/542 (2017.08); C07C 269/04 (2013.01); C07C 269/06 (2013.01); C07C 271/02 (2013.01); C07C 323/60 (2013.01); C07K 1/04 (2013.01); C07K 1/1077 (2013.01); C07K 14/00 (2013.01); C07K 14/4703 (2013.01); C07K 14/473 (2013.01); C07K 14/505 (2013.01); C07K 14/575 (2013.01); C07K 14/57509 (2013.01); C07K 14/605 (2013.01); C07K 14/62 (2013.01); C07K 14/635 (2013.01); C07K 14/695 (2013.01); A61K 38/00 (2013.01); C07C 2603/18 (2017.05);
Abstract
The present invention relates to peptide modifier compounds of Formula (1), or a salt thereof, wherein: a is an integer from 1 to 10, more preferably from 1 to 3; b is an integer from 0 to 7; Z is a terminal group and Y is a bivalent group. Further aspects of the invention relate to intermediates in the preparation of compounds of Formula (1), and the use of compounds of Formula (1) in the synthesis of peptide derivatives.